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EFFECT OF INSULIN AND V ANADATE ON SRE-MEDIATED C-FOS
EXPRESSION AND JNK ACTIVATION
Francisco J. Berguido, M.S.
Western Michigan University, 1997
Insulin mimetics are compounds that mimic the action of insulin in the body
and are currently being studied as possible therapeutic agents against diabetes.
Vanadium has been identified as an element with insulin-like properties with regard
to metabolic processes such as lowering blood glucose levels. Few studies have
implicated vanadium in mitogenic actions such as cell growth and differentiation. We
studied the action of vanadate on the expression of the insulin-induced SRE, a cis
element of the well-characterized mitogenic gene c-fos. We measured this expression
by means of a plasmid containing the reporter gene luciferase linked to the sequences
from c-fos containing the SRE (SRE-Luc). We also examined activation of signal
proteins that might be responsible for the insulin induction of SRE-Luc.
This study showed that insulin increased expression of SRE-Luc in a time
dependent fashion, vanadate had no effect on the expression of SRE-Luc. Use of
inhibitors of the PI3K and MAPK pathways suggested that PI3K is necessary for
insulin induction of SRE-Luc and PI3K maybe located somewhere between Ras and
MEK. The use of inhibitors also helped determine that both, MAPK and PI3K
pathway proteins may also be necessary for the insulin-induced expression of SRE
Luc. Additionally, we assessed JNK activity in the presence of insulin and vanadate.
Our results indicate that insulin and not vanadate activate JNK, a close relative of
MAPK.
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CHAPTER I
INTRODUCTION
Insulin, Insulin-Mimetics and Diabetes
Insulin action in the cell includes regulation of glucose and ammo acid
transport; activation of important enzymes in intermediary metabolism; modulation of
protein, DNA and RNA synthesis; and regulation of cellular growth and
differentiation (Saltiel, 1996; Jhun et al., 1995; Levy-Toledano et al., 1995). Any or
all of these processes can be affected in disease states such as in insulin-dependent
diabetes mellitus (IDDM) or non-insulin-dependent diabetes mellitus (NIDDM),
conditions in which insulin is not produced or recognized adequately. In recent years,
attention has been given to the use of elements and compounds with insulin-like
effects to potentially treat IDDM and NIDDM. These compounds are commonly
known as insulin mimetics (Weinstock et al., 1992; Balon et al., 1995; Esaki, 1990,
Stapleton et al., 1997).
One of these mimetics is vanadium (vanadate), a transition element commonly
found in the earth's crust. Vanadium has been shown to stimulate glucose transport
in rat adipocytes and mouse skeletal muscle; and increase lipolysis, glucose oxidation
and glycogen synthase in rat adipocytes (Goldfine et al., 1995). Its administration in
oral doses has been found to reduce levels of blood glucose in diabetic animal models
(Goldfine et al., 1995; Yale et al., 1995; Stapleton et al., 1993). Vanadium is also
involved in regulation of DNA synthesis as well as in inducing expression of several
genes that are usually increased in the presence of insulin (Weinstock et al., 1992;
Chen and Chan, 1993; Imbert et al., 1994; Stapleton et al., 1993). Because of the
1
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many documented studies about its insulin-like action, vanadium has recently been
proposed for human clinical trials as a possible therapeutic agent for several forms of
diabetes (Borman, 1994).
However, before concluding that this element completely mimics the effect of
insulin intracellularly, it is relevant to determine the extent of the insulin mimetic
action of vanadate in the cell. Within the cell, insulin induces metabolic actions such
as lowering blood glucose levels, as well as mitogenic actions which are associated
with cell growth and differentiation. Although vanadate mimics the metabolic action
of insulin, its role in the insulin-like mitogenic effects has not been clearly identified
(Yale et al., 1995). This aspect of insulin action should be mimicked by vanadate in
order to consider this element a true insulin-like substance.
In order to determine the mechanism of action of vanadate as well as its
effects as an insulin mimetic, it is first, necessary to understand the intracellular
mechanism of insulin action.
Insulin and Its Signal Transduction Mechanism
Intracellularly, insulin triggers a series of events, including transient protein
phosphorylation and dephosphorylation, that are responsible for the insulin induced
cellular effects. This cascade of events that triggers the regulation and modulation of
mitogenic and metabolic effects of insulin in the cell is known as the insulin signal
transduction cascade (Saltiel, 1996).
The first step in insulin signal transduction is the autophosphorylation of the
insulin receptor (Saltiel, 1996; Jhun et al., 1995). The insulin receptor (IR) is a cell
surface heterotetrameric protein complex with two alpha and two beta subunits
(Saltiel, 1996; Zick, 1989). The alpha subunits contain the insulin binding domains,
the beta subunits contain the tyrosine kinase activity (Saltiel, 1996; Lee and Pilch,
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1994). Upon insulin binding to its receptor, autophosphorylation occurs via
crossactivation of the beta subunits (Saltiel, 1996; Jhun et al., 1995).

This

autophosphorylation increases its kinase activity and results in the activation of
downstream proteins (Saltiel, 1996). These activated proteins can be classified, based
on their interactions, into two main groups or pathways: The IRS-1/PBK and the
Ras/MAPK pathways.
Insulin Signal Transduction Cascade - The IRS-1/PBK Pathway
One of the proteins that has been identified as a target of the activated IR
(Biener et al., 1996), is the insulin receptor substrate 1 (IRS-1), a 185kDa protein with
several tyrosine phosphorylation sites (Saltiel, 1996). This protein can interact with
the src homology (SH) 2 domains of a membrane-bound kinase known as PBK
(Saltiel, 1996; Yamauchi et al., 1993) (Figure 1).
PI3K and Its Signal Cascade
In mammals, there are several known classes of phosphatidylinositol 3-kinase
(PI3K) (Ireton et al., 1996; Carpenter and Cantley, 1990). The best characterized for
its effects in signal transduction, is a heterodimer composed of an 85kDa regulatory
subunit (p85) and a ll0kDa catalytic subunit (pl l 0) (Wang et al., 1995), each of
which exists in at least two isoforms (a and �) (Ireton et al., 1996; Inukai et al.,
1997). p85 contains an SH2 domain, a break point region (bpr) homology domain
inserted in the middle of two proline rich sequences and two SH2 domains flanking a
pl IO-binding region (Wang et al., 1995).
PBK phosphorylates phosphatidylinositol (PI), PI 4-phosphate and PI 4,5bisphosphate at the D-3 hydroxyl position of the inositol ring. (Wang et al., 1995;
Ireton et al., 1996; Kamitz et al., 1995; Carpenter and Cantley, 1990).
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Several growth factors in addition to insulin, are capable of activating PBK
(Saltiel, 1996).

PBK activation by insulin and other growth factors has been

correlated with membrane trafficking and ruffling, glucose and thymidine utilization
and actin polymerization (Saltiel, 1996; Denton and Tavare, 1995; et al., 1996; Suga
et al., 1997; Harada et al., 1995; Lazar et al., 1995; Gabbay et al., 1996; Ireton et al.,
1996; pePaolo et al., 1996; Hara et al., 1994). Other studies have also shown the
involvement of PBK in activation of gene expression associated with regulation of
cell growth and mitogenesis (Hu et al., 1995; Karnitz et al., 1995; Hawes et al., 1996).
Point mutations in the PBK binding sites of the PDGF receptor, for example, impairs
the ability of this receptor to mediate expression of several genes (Wang et al., 1995).
Two components of the PBK cascade which were found downstream of PBK
have been identified as ribosomal S6 protein kinase (p70S6Kinase) and PKB/c-Akt
(Burgering et al., 1995; Monfar et al., 1995). In vitro assays show that Akt is capable
of p70S6Kinase activation, suggesting that p70S6Kinase is downstr!arr.r .of A.kt
(Burgering et al., 1995).
Another protein implicated in the PBK cascade is the FKBP-Rapamycin
Associated Protein (FRAP). FRAP (also known as RAFT in the rat system) is a
289kDa protein (Choi et al., 1996). This protein is characterized by a C-terminal
kinase domain homologous to phosphatidylinositol kinases (Choi et al., 1996; Brown
et al., 1995) (Figure 1).
FRAP, which is sensitive to the immunosupressant rapamycin is required to
bind p70S6Kinase for PBK-mediated activation (Choi et al., 1996; Brown et al.;
1995; Monfar et al., 1995; Mahalingam, et al., 1996) (Figure 1).
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InsulinSignal TransductionCascade - The Ras/MAPK Pathway
Autophosphorylation of the insulin receptor results in the activation of a
second group of proteins which forms the Ras/MAPK pathway. This cascade is
initiated with the phosphorylation of members of theShe family of proteins. Several
members of the She family are phosphorylated via SH2 domains (Czech, 1995;
Saltiel, 1996). Phosphorylation of She by IR results in activation of an adaptor
protein: Grb2 (Saltiel, 1996). Grb2-Shc associates with a protein known as son of
sevenless (SOS) on the SH3 domains of Grb2 (Su and Karin, 1996; Skolnik et al.,
1993). Activated SOS acts as a guanine nucleotide exchange factor for a small G
protein at the plasma membrane, Ras (Czech, 1995; Saltiel, 1996; Holt et al., 1996;
Jhun et al., 1994) (Figure 1).
Ras is an inner leaflet plasma membrane associated guanme nucleotide
binding protein that becomes activated upon several stimuli that are r�lated to cell

,.

,..

growth and differentiation (Jelinek et al., 1994; Avruch et al., 1994). Upon insulin
presence, Ras activation results in the activation of a family of proteins: theMAPK' s
(Medema et al., 1991; O lefsky et al. 1993; Miller et al., 1996) (Figure.I).
TheMAPK's
Mitogen-Activated Protein Kinases (MAPK's) are a family of protein kinases
that

become activated by

a

praline-directed phosphorylation

at

specific

serine/ threonine residues (Su and Karin , 1996; Avruch et al., 1994).
Several studies with inhibitors of the MAPK pathway have determined that
activation of the MAPK associated signal cascade is not sufficient for the regulation
of glucose transport by insulin. However, activation of these proteins has been
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directly associated with several aspects of cell growth and differentiation (Saltiel,
1996; Gabbay et al., 1996; Myers et al., 1994; Lazar et al., 1995).
There are several known members of the MAPK family which have been
cloned. This family includes the extracellular signal regulated kinases (ERK's) 1, 2,
3, and 5, Jun-N-terminal Kinase/Stress-activated Protein Kinase (JNK/SAPK), Fos
regulating kinase (FRK) and p38/Mpk2 (Su and Karin, 1996; Childs and Mak, 1993).
During the insulin stimulation of the signal cascade, MAPK's are known to
translocate to the nucleus and regulate gene expression by phosphorylating
transcription factors such as Elk-1 which regulates the expression of c-fos (Saltiel,
1996; Medema et al., 1991).
The activating signals for ERK's 1 and 2 are specific extracellular stimuli
associated with cell growth and differentiation, such as serum, cytokines and growth
factors. These signals are different from the signals that activate the ERK-related
protein kinases, JNK, p38 and FRK (Deng and Karin, 1994).
ERK 1/2 Activation
In order to phosphorylate and therefore activate ERKl/2, Ras must first
phosphorylate three different MAPKKK's: Raf-1 (Karin, 1995; Leevers et al., 1994;
Jelinek et al., 1994), c-Mos and MEKKl (Davis, 1993; Su and Karin, 1996; Avruch et
al., 1994).

These MAPKKK's are protein kinases that phosphorylate the MAP

kinase�rK-activating Kinases, MEKl and MEK2 (Karin, 1995; Dent et al., 1992;
Jelinek et al., 1994; Blenis, 1993). MEKl/2 are dual specific (tyrosine and ser/thr)
kinases that are directly responsible for the phosphorylation of ERKl/2 (Karin, 1995;
Crews et al., 1992; Avruch et al., 1994) (Figure 1).
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JNK/SAPK Activation
Ras is responsible, through Raf-1, for the activation ofMEKKl . MEKKl has
been implicated in ERKl /2 activation, however, most ofMEKKl activation results in
JNK phosphorylation (Minden et al., 1994).

MEKKl is a Ser/Thr kinase that

activates JNK.Kl (Karin, 1995; Minden et al., 1994; Lange-Carter 94, Cavigelli et al.,
1995). JNK.Kl , also known as SEKI or MKK4, is the kinase that phosphorylates and
activates JNK (Derijard et al., 1995; Lin et al., 1995; Gerwins et al., 1997) (Figure 1).
JNK is activated mainly by stress related signals such as UV irradiation,
osmotic stress, treatment with translational inhibitors, exposure to IL-1, ischemia and
reperfusion (Su and Karin, 1996; Rosette and Karin, 1996; Adler et al., 1995;
Morooka et al., 1995). However, JNK activation is also seen upon treatment with ·
EGF and other hormones albeit to only about one third of the levels of ERK
activation (Su and Karin, 1996).
,,.

·�

Insulin and Vanadate
As reviewed in the previous pages, the insulin signal cascade is a complex
series of events that help target insulin action in the cell. Any insulin mimetic that
could potentially be used in insulin replacement therapy must be tested with regard to
its ability to similarly activate the proteins involved in the insulin signal transduction
cascade.
Vanadate has been identified as an insulin mimetic in terms of metabolic
processes such as glucose transport and protein synthesis. These insulin-like effects
ofvanadate maybe mediated through the activation ofinsulin signal cascade elements
such as the insulin receptor �-subunit autophosphorylation and IRS-1 (Goldfine et al.,
1995; Yale et al., 1995, Ruff et al., 1997).
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In order to determine the insulin-like actions of vanadate in regulating gene
expression through the insulin signal cascade, we proposed to study the insulin
activation of a reporter construct that carries the serum response element (SRE) of c
fos. SRE is the cis-element used by insulin in mediating expression of this gene. If
vanadate truly mimics insulin action, then it should, in a mechanistically similar
fashion to insulin, increase expression of this reporter construct.
Insulin in the Activation of c-fos
In early studies regarding activation of c-fos, it became apparent that insulin
was one of many growth factors that produced a transient increase in the expression
of this gene (Jhun et al., 1995; Thompson et al., 1994; Hattori et al., 1988). However,
little was known regarding the cis-element responsible for the insulin induced
activation of c-fos expression. Consequently, experiments were carried out in order
to determine the exact sequences that respond to c-fos expression by insulin presence
in the cell. It was found that mutation of four base pairs of a c-fos cis-element, later
termed Serum Response Element (SRE), abolished expression of this gene by serum
and insulin (O'Brien et al., 1996; Treisman, 1986). The Serum Response Element,
which is located between -314 and -305 of the c-fos promoter was shown to be
responsible in part for the insulin induction of c-fos (Treisman, 1986). Other studies
have indicated that additional sequences present in the c-fos promoter are necessary in
order to carry out a full response (Treisman, 1986; O'Brien et al., 1996). Yamauchi et
al. demonstrated that an 80bp sequence surrounding the SRE region (-357 to -276)
conferred a 14 fold increase in SRE expression when measured by means of the
reporter gene luciferase (Yamauchi et al., 1993; de Wet et al., 1987).

Another

plasmid containing a shorter sequence of only the SRE region (SRE-Core) (-320 to 298) was also constructed and, upon insulin stimulation, produced only an
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approximate 4-fold increase (Yamauchi et al., 1993). Yamauchi's studies demostrate
that while the SRE is capable of mediating an insulin induced increase in c-fos
expression, the region surrounding the SRE is necessary for the full transcriptional
response that is observed in vivo.
Even though, several groups have tried to determine which pathways are
involved in SRE-mediated expression of c-fos by insulin, little can be concluded.
These results seem to be cell specific, depending on the mitogenic or metabolic
characteristics of the cells. (Olson and Pessin, 1994; Saltiel et al., 1994; Saltiel, 1996).
Regulation of c-fos Expression: General Aspects
The expression of c-fos is now known to be regulated, at least in part, by its
three known cis-elements: the cyclic AMP response element (CRE), the Serum
Response Element (SRE) and the Sis-Inducible Enhancer (SIE) (Cavigelli et al.,
1995). The first two are constitutively occupied in non-stimulated cei.1s, ·.v�le the
third element is occupied only after specific stimulation (Cavigelli et al., 1995;
Herrera, 1989) (Figure 2).
There are specific transcription factors that recognize each one of the cis
elements in the c-fos promoter. CRE is recognized by CREB and other similar
transcription factors such as CREM and ATF-1 (Cavigelli et al., 1995; Mayer and
Habener, 1993). CRE is responsible for the expression of c-fos when stimulated by
neurotransmitters and hormones that use cAMP or Ca++ as second messengers. The
induction of the gene at CRE is produced by activation of protein kinase A or
calmodulin-dependant protein kinases (Karin, 1995; Sheng et al., 1994). The SIE is
recognized by members of the transcription factor family, STAT (Cavigelli et al.,
1995) (Figure 2). SRE is specifically recognized by a bi-protein complex formed by a
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serum response factor (SRF) and a ternary complex factor (TCF) (Cavigelli et al.,
1995; Treisman, 1994).
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c-fos

Regulation of c-fos Transcriptional Response by Diverse Extracellular
Stimuli .
The c-fos Serum Response Element

The Serum Response Element (SRE) of the c-fos promoter contains a
sequence comprised of a CArG box [CC (A/T)6 GG] located near at least one DNA
binding site (Gille et al., 1996; Latinkic et al., 1996). SRE initiates transcription of c
Fos upon binding of the Serum Response Factor (SRF) and the Ternary Complex
Factor (TCF), forming a ternary complex (Treisman, 1994; Treisman, 1986)
(Figure 3).
This large complex has been identified as the element that binds the extended
sequences described previously in Yamauchi's studies (Yamauchi et al., 1993).
There are several models that describe the way in which the formation of the
ternary complex occurs. Even though, some discrepancies exist regarding the series
of events that are required for ternary complex formation, all these models agree that
ternary complex occurs when: SRF becomes phosphorylated (Hill et al., 1995,
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Franzoso et al., 1996), phosphorylated SRF binds to SRE (Cavigelli et al., 1995,
Rivera, 1993), TCF becomes phosphorylated, phosphorylated TCF binds to SRF and
its DNA binding site to complete the ternary complex (Cavigelli et al., 1995; Gille et
al., 1992, Gille et al., 1995; Latinkic et al., 1996, Gille et al., 1996; Price et al., 1995).

c-jun

\
Figure 3.

/

Activation ofFos and Jun by MAPK's. a. Representation ofthe
ternary complex formation

SRF is rapidly phosphorylated upon mitogenic stimuli and/or stimuli
associated with nuclear targets mediated by the Rho family of GTPases (Rivera,
1993; Hill et al.,1995a; Treisman, 1995). The major regulatory mechanisms in the
formation of the ternary complex is therefore the phosphorylation of TCF (Cavigelli
et al., 1995; Hill et al., 1994).
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Elk-1/TCF Phosphorylation
Ternary complex factor is a generic name used to describe a family of
transcription factors that are required in the formation of the ternary complex in order
to initiate transcription. TCF requires binding of SRF and SRE to form the ternary
complex (Treisman, 1995).
Most of the TCF's are members of a family of transcription factors, which
include Elk-1, SAP-1, and NET-1/ERP/SAP-2 (Whitmarsh et al., 1995; Latinkic et
al., 1996). The first TCF to be identified and also the best studied is Elk-1 (Cavigelli
et al., 1995; Hipskind, 1991). Elk-1 has several phosphorylation sites by its c
terminal domain, these phosphorylation sites are conserved in many of the TCF's
(Cavigelli et al., 1995; Gille et al., 1992; Karin, 1995; Treisman 1994, Price et al.,
1995; Latinkic et al., 1996).
Several in vitro studies have shown that the proteins responsible for the
phosphorylation of Elk-1 are ERK.1 and ERK.2 MAPK's. Purified, these MAPK's
phosphorylate Elk-1 in the exact same phosphorylation sites where Elk-1 is
phosphorylated upon extracellular mitogenic stimuli in vivo (Cavigelli et al., 1995;
Gille et al., 1992, 1995; Marais, 1993; Zinck, 1993; Whitmarsh et al., 1995; Cano et
al., 1995; Price et al., 1995) (Figure.3).
Another member of the MAPK family, the Jun-N-terminal Kinase (JNK) is
also known to phosphorylate Elk-1 in order to induce SRE-mediated c-fos expression,
but in response to different stimuli, for example UV irradiation (Cavigelli et al., 1995;
Derijard et al., 1994; Whitmarsh et al., 1995) (Figure 3).
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Objectives of the Study
If we are to fully understand the action of vanadate in terms of mimicking
insulin, we need to address the issue of whether or not vanadate can similarly
stimulate the expression of a well-characterized mitogenic gene, c-fos, through a well
characterized insulin response element, the SRE. For that purpose, we obtained the
SRE-Luc construct utilized by Yamauchi et al., in the study described above
(Yamauchi et al., 1993).
We hoped to link activation of part of the insulin signal cascade to the insulin
activation of this construct. We then planned to similarly test vanadate to not only
activate the expression of the SRE-Luc construct but also to link this activation to the
same signal proteins used by insulin. To do so, several inhibitors of the MAPK and
PI3K signal cascades were used to block one signal cascade at a time and show that
this pathway was utilized by insulin and/or vanadate in the activation of SRE
mediated c-fos gene expression in primary rat hepatocytes in culture.
Additionally, we wanted to determine the effect of insulin and vanadate on the
activity of JNK, since the Jun-N-terminal Kinase (JNK) is implicated in the
phosphorylation of Elk-I, a necessary step in ternary complex formation and
activation of SRE-mediated c-fos expression.

CHAPTER II
MATERIALS AND METHODS
Materials
The SRE-Luc plasmid (Yamauchi et al., 1993) was a generous gift of Dr.
Jeffrey Pessin, Department of Physiology and Biophysics, The University of Iowa,
College of Medicine, Iowa City, Iowa.
Male Sprague-Dawley rats were obtained from Harlen Sprague-Dawley
(Kalamazoo, Ml). Waymouth's MB 752/1 medium, Lipofectin, restriction enzymes
and gentamicin were purchased from Gibco BRL (Grand Island, NY). DNase-free
RNase and Collagenase D were purchased from Boehringer Mannheim Biochemicals
(Indianapolis, IN). Phenol was purchased from Amresco (Solon, OH). Insulin was a
gift from Eli Lilly Corp. (Indianapolis, IN). Rat tail collagen (type N) was obtained
from Collaborative Research Incorporated (Bedford, MA).

SAPK/JNK and

Luciferase Assay Kits were purchased from New England Biolabs (Beverly, MA) and
Promega (Madison, WI), respectively. Hyperfilm was purchased from Amersham
Life Science (Arlington Heights, IL). Nucleobond AX kit for plasmid purification
was purchased from The Nest Group (Southboro, MA).
The MEK inhibitor PD 98059 was generously provided by Dr. Alan Saltiel,
Parke-Davis Warner Lambert Pharmaceutical Research Division, Ann Arbor, Ml.
The PI-3 kinase inhibitor wortmannin was purchased from Sigma Chemical Corp. (St.
Louis, MO).

Famesyltransferase inhibitor B581 and a PI-3 kinase inhibitor LY

29004 were purchased from Biomol Research Laboratories (Plymouth Meeting, PA).
The FRAP inhibitor Rapamycin was purchased from Calbiochem (San Diego, CA)
15
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All other reagents were obtained from Sigma Chemical Corp. (St. Louis, MO).
Extraction and Purification of Plasmid DNA
SRE-Luc transformed E-coli DH5-a bacterial cells were grown in lL of LB
medium (lL=l 0g Bacto-tryptone, 5g Bacto-yeast extract, 10g NaCl) overnight at 37
�C. The bacterial cells were harvested at 2000xg for-30 min at 4 °C. The pellet was
lysed by the alkali method as described by Sambrook, Fritsch and Maniatis
(Sambrook, Fritsch and Maniatis, 1989) by first, resuspending it in 10 ml of solution
A (50 mM glucose, 25mM Tris.HCl, pH 8.0, l0mM EDTA, 5mg/ml lysozyme) and
then, subsequently in 20 ml of solution B (0.2 N NaOH, 1% SDS) and 15 ml of
solution C (3M potassium acetate and glacial acetic acid). The bacterial lysate was
centrifuged at 15000xg for 30 min at 4 °C. Nucleic acids were precipitated by
isopropanol and RNA degraded by incubation with DNase-free RNase (2000 U/ml
activity). Further purification was obtained by phenol-chloroform extraction. The
plasmid DNA was precipitated by adding ammonium acetate (final concentration 2M)
and 100% ethanol. Plasmid was visualized by 1% agarose gel electrophoresis. Final
purification of the plasmid was carried out by an ion-exchange chromatography
column using the Nucleobond AX kit (The Nest Group, Southboro, MA).

The

concentration of the plasmid was determined by UV-Vis spectrophotometry
(absorbances 260nm and 280nm).
SRE-Luc Restriction Digestion
Once the plasmid was isolated, a series of restriction digestions were carried
out to confirm the DNA insert. The restriction enzymes BamHI (10 U/µl, Gibco
BRL) and Hindlll (10 U/µl, Gibco BRL) were used to cleave the plasmid in three
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places. The fragments were compared to the original plasmid map (Figure 4) and
subsequently, electrophoresed and separated by size (Figure 5).

SRE-Luc

BamHI>·

PolyA

SRE

Luciterase

t

Figure 4.

SRE-Luc Plasmid (5.5kb). Representation of plasmid containing a
dyad of the SRE-c-fos, the tk promoter, and the luciferase gene.
Hepatocyte Isolation and Maintenance

Hepatocytes were isolated by the collagenase-hyalurodinase perfusion method
as described by Stapleton et al. (Stapleton et al., 1993).
Male Sprague-Dawley rats (Harlan Sprague-Dawley, Kalamazoo, MI)
between 200 and 300 g were food-deprived 48h prior to hepatocyte isolation in order
to minimize blood insulin levels.

Rats were anesthetized with 50 mg/ml

pentobarbitol. These procedures conformed to NIH guidelines for animal care and
use and were approved by IACUC (refer to appendix B). After the collagenase-
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hyalurodinase perfusion, the liver was removed from the animal and passed through
four layers of gauze for its dissociation into cells.

Figure 5.

Restriction Digestion of the SRE-Luc Plasmid.
The figure indicates the approximate size in Kb of the
DNA fragments compared to a DNA ladder. Lane 1.
represents the 1 Kb DNA ladder. Lane 2. shows the
SRE-Luc plasmid prior to digestion. Lane 3. indicates
the plasmid subjected to restriction digestion as
indicated in Materials and Methods. The lines
beside lane 3 indicate the position of the fragments.

The cells were washed twice with cold-serum free Waymouth's MB 752/1
medium (Gibco BRL, Grand Island, NY) plus 0.5% bovine serum albumin (BSA).
This high protein content medium decreased cellular stress caused by the isolation
procedure. The cells were then centrifuged for 3 min @ 4 °C and 50xg. The pellet
was gently resuspended in medium and an aliquot of cells was counted with a
hemocytometer.

Cell viability was determined by trypan blue dye exclusion.

Collagen coated 60mm tissue culture dishes were plated with 3.0X106 cells/plate, if
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cell were greater than 80% viable. The cells were incubated@ 37 °C in serum free
Waymouth's MB 752/1 medium supplemented with gentamicin (l 0µg/ml) under a
humidified atmosphere of 5% CO2 and 95% air. After about 4 hours of incubation, a
time considered adequate for the cells to have stabilized and adhered to the plates, the
hepatocytes were washed and fresh medium without BSA applied.

After cell

stabilization and adhesion, it was necessary to removed BSA from the medium due to
its random binding properties, which could alter the parameters of the experiment .
Cell Treatment for SRE-Luc Transfection
Approximately four hours after the last medium change, five micrograms of
SRE-Luc plasmid per plate was transiently transfected using Lipofectin (Gibco BRL)
(Rank et al., 1994). After a 12-hour transfection period, cells were simultaneously
treated with either nothing (control), 500nM insulin, 500µM sodium orthovanadate
and/or respective inhibitors. The concentration used for insulin, vanadate and each
one of the inhibitors were based either on our previous studies or as a result of others
documented in the literature (Sutherland et al., 1995, Cox et al., 1994; Vlahos et al.,
1994). After incubation, the cells were harvested in lysate buffer provided in the
luciferase assay kit (Promega).

Luciferase activity was measured following the

protocol in the Promega kit and activity was quantified in a liquid scintillation
counter. Protein levels were measured using the Lowry method (Lowry et al., 1951).
Cell Treatment for Determination of JNK Activation
Preliminary studies carried out in our laboratory suggested that the optimal
times for JNK activation upon insulin and sodium orthovanadate treatments, were 10
minutes and 1 hour respectively (data not published).

After 10 min of insulin

(500nM) and lh of sodium orthovanadate (500µM) treatment, cells were washed

20
twice with ice-cold PBS. Cells were scraped and processed in the buffer provided by
the JNK assay kit (New England Biolabs, Beverly, MA). The cell extracts were
sonicated four times for five seconds each using level 5 on a 50 Sonic Dismembrator
(Fisher Scientific, Pittsburgh, PA) and centrifuged at 11000xg for five minutes @ 4
�C. The supernatant was used to carry out the JNK assays.
JNK Assay and Western Analysis Detection
The protein JNK was assayed in cell extracts that were incubated overnight
with c-Jun fusion protein beads provided in the JNK assay kit. After overnight
incubation, the samples were microcentrifuged for two minutes @ 4 °C. The pellets
were washed once with lysis buffer and once with kinase buffer, both of them
provided in the JNK assay kit. ATP ( l 00µM) was added to the samples in order to
initiate the phosphorylation reaction. The reaction was terminated by 3X SDS sample
buffer (1X=62.5 mM Tris-HCl, 2% SDS, 10% glycerol, 50 mM DTT, 0.1
bromophenol blue). The samples were then boiled for 5 min and microcentrifuged for
2 min in order to release the beads. The supernatant was electrophoresed in a 10%
polyacrylamide gel and transferred to a PVDF membrane using a standard semi-dry
electroblotting apparatus (NOVEX, San Diego, CA).
After transfer, the membrane was blocked for 1 to 3h with blocking buffer (IX
Tris-Buffered Saline, 0.1% Tween-20 with 5% non fat dry milk). The membrane was
then probed with phospho-specific c-Jun antibody (1: 1000 dilution, provided in the
JNK assay kit) in primary antibody dilution buffer (IX TBS, 0.05% Tween-20 with
5% BSA) overnight @ 4 °C. The membrane was washed several times with Tris
buffered saline plus Tween 20 (TBST IX, 1L=2.42g of 20mMTris Base; 8g of
137mM NaCl; 3.8ml of IM HCl; and 1ml Tween 20) prior to incubation for one hour
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with two antibodies: HRP-conjugated anti-rabbit secondary antibody (1:2000) and
HRP-conjugated anti-biotin antibody (1:1000, to detect biotinylated markers).
Detection of the phosphorylated proteins was carried out by incubation in lX
LumiGlo solution of the Phosphotope-HRP system provided in the JNK assay kit.
The membrane was exposed to Hyperfilm (Amersham Life Science, Arlington
Heights, IL) and bands were quantified using an optical densitometer.
Statistical Analysis
The results are expressed as the mean± S. E. Significance was evaluated by
one-tailed Student's t-test and tested at p<0.05.

CHAPTER III
RESULTS
Restriction Digestion of SRE-Luc Plasmid
The plasmid was amplified and isolated as described m Materials and
Methods. According to the restriction map, the SRE-Luc plasmid contained two
restriction sites for BamHI and one for HindIII, (Figure.4). After digestion with these
restriction enzymes, the fragments were subjected to electrophoresis in a 1 % agarose
gel. Three DNA fragments were visualized by placing the gel under UV light after
ethidium bromide staining (Figure 5). By comparing the sizes of the restriction
fragments to a DNA ladder, the estimated sizes of the restriction fragments were 0.5,
2.0 and 3.0kb. The fragments corresponded to the plasmid portions that o.::ontatned the
tyrosine kinase promoter plus an SRE dyad (432bp), the luciferase gene (1811bp) and
the remainder of the vector (2.8kb) (Yamauchi et al., 1993; Chen et al., 1987; de Wet
et al., 1987). Therefore, the restriction map analysis confirmed the SRE-Luc plasmid
reported by Yamauchi et al.
Effect of Insulin and Vanadate on SRE-Luc Expression
In order to determine the specificity of insulin induction of SRE-Luc m
primary rat hepatocytes in culture, the cells were first transiently transfected with the
plasmid, then incubated with insulin (500nM) for the following times: 5 min, 30 min,
lh, 3h, 6h, and 12h.
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A significant insulin-induced increase in expression of the plasmid as
measured by an increase in luciferase activity was not observed prior to lh of
incubation with insulin (Figure 6).

0
0
0

2.00
1.50
1.00
0.50
0.00

NA

Figure 6.

I 3h

I6h

I 12h

Primary rat hepatocytes in
Effect of Insulin on SRE-Luc.
culture were treated with nothing (control or NA) or insulip. (5.P0nM)
for the SRE-Luc. Values represent the means±S.E. Asterisk(*)·
indicates significant stimulation (p<0.05). Minimum experiment per
condition=3, except I 12h where n=2.

As shown in Figure. 6, the insulin-induced increase over control in SRE-Luc
expression reached approximately 1.6 fold at 3h. Incubation of insulin for 6h resulted
in approximately a 3 fold increase of SRE-Luc over non-stimulated control. A later
incubation time of 12h showed a considerable decrease in the expression of the
plasmid, suggesting that the insulin-induced expression of SRE-Luc was transient
(Figure 6).
In order to determine whether or not vanadate could m1m1c the insulin
induction of SRE-Luc in these cells, we incubated transfected cells with sodium
vanadate (500µM) for lh, 3h and 6h. As summarized in table 1, incubation of
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hepatocytes with vanadate did not induce the expression of transiently transfected
SRE-Luc to any significant extent for any of the time points analyzed.
Table 1
Effect of Vanadate on SRE-Luc in Primary Rat Hepatocytes

Treatment

SRE-Luc Levels {IS% of Control

Control

100

Vlh

1.07±0.49

V3h

1.11±0.35

V6h

0.98±0.23

Primary rat hepatocytes in culture received no treatment (control) or were treated with
vanadate (V) (500µM) for the times indicated. The control of each experiment was
arbitrarily set to 100 and the change by treatment with vanadate was expressed
compared to the control value. Data shown are the means±S.E. * =significantly
different from control, p<0.05. n=4.
In conclusion, these studies suggest that activation of SRE-Luc expression in
primary rat hepatocytes in culture by insulin occurs in a time-dependent fashion with
a maximum increase observed at 6h of incubation. Surprisingly, vanadate, a known
insulin mimetic, did not induce the activation of SRE-Luc expression at any of the
time points considered. These results suggest that vanadate does not mimic insulin
with regard to the regulation of gene expression through an SRE.
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Effect oflnhibitors of the Insulin Signal Transduction Pathways
on Insulin-induced SRE-Luc Expression
In order to determine the role of insulin signal transduction proteins in the
insulin activation of SRE-Luc expression, we used several inhibitors of the PBK and
MAPK pathways.
Inhibitors of PBK Activation: Wortmannin and LY 294002
Wortrnannin (WT) is a fungal metabolite that inhibits the kinase activity of
PBK by covalently binding to the catalytic subunit of the enzyme (Ui et al., 1995;
Norman et al., 1996). This inhibitor becomes unstable at room temperature after 2h
of incubation at pH 7.0 (Norman et al., 1996). Studies utilizing the inhibitor for
longer incubation times require re-addition of WT to the incubation medium every
two hours (Shepherd et al., 1995).
As shown in Figure 7, wortrnannin (l00µM) completely inhibiteJ th.; insulin
induced expression of SRE-Luc.
Since WT has been reported to inhibit the PBK pathway in a non-specific
fashion, a mechanistically different and more specific inhibitor of PBK, LY 294002,
was also used (Vlahos et al., 1994).

LY 294002 inhibits PBK by specifically

interacting with the ATP-binding site of the enzyme (Vlahos et al., 1994). As shown
in Figure 7, LY 294002 (50µM) also completely inhibited the insulin-induced SRE
Luc expression
Since both, WT and LY 294002 were effective inhibitors of the insulin
induced SRE-Luc expression, these results suggest that activation of PBK is a
necessary step in the expression of this plasmid by insulin in primary rat hepatocytes.
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Effect of Insulin and Inhibitors of the PBK Cascade on SRE-Luc
Expression. Primary rat hepatocytes in culture were treated with
nothing(control/ NA) or insulin(500nM) plus the designated inhibitor
of the PBK cascade. Values represent the means±S.E. Asterisk(*)
indicates significant stimulation(p<0.05). Double asterisk(**)
indicates significant inhibition(p<0.05). Minimum experiment per
condition= n= 3.
►

Rapamycin: Inhibition of FRAP Activation
FKBP-Rapamycin-Associated Protein (FRAP) is a downstream effector of
PBK that is, at least in part, responsible for the activation of p70S6Kinase(Choi et al.,
1996; Shepherd et al., 1995; Brown et al., 1995; Monfar et al., 1995).
In order to determine the role of FRAP in the activation of SRE-Luc
expression by insulin, the imrnunosuppressant rapamycin was used(Price et al., 1992;
Choi et al., 1996). Rapamycin is an inhibitor of FRAP that interacts at a hydrophobic
pocket within the protein and blocks its activation(Choi et al., 1996).
As shown in Figure 7, rapamycin(100nm) inhibited the insulin-induced SRE
Luc expression. The 3.0 fold insulin-induced increase in expression of SRE-Luc was
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decreased to 1.40 fold upon rapamycin treatment (1OOnM). This represented a partial
inhibition ofthe insulin-induced SRE-Luc expression.
These results suggest that the events responsible for the insulin induced
expression ofSRE-Luc require, at least in part, an activated FRAP.
B581: Inhibition ofRas Activation
In order for Ras to obtain an adequate conformation necessary for its
membrane interaction and activation, this protein must undergo a series of post
translational modifications.

Ras post-translational modifications, which include

proteolysis, methylation and famesylation, are triggered by a consensus COOH
terminal CAAX motif (A=aliphatic residue) (Cox et al., 1994). In several cell types,
B581 has been shown to act at the CAAX motif of famesylated Ras causing
inhibition ofRas activation (Gabbay et al., 1996; Cox et al., 1994).
As shown in Figure 8, B581 (50µM) partially inhibits the SRE-Lur. �nduced
expression by insulin. The 3.0 fold increase of SRE-Luc expression by insulin was
slightly decreased to 2.5 fold upon B581 treatment.
Inhibition ofMEK Activation by PD 98059
The MAP kinase/ErK-activating Kinases (MEK's) are downstream effectors
of Ras that are implicated in the activation of ERKl/2 MAPK's (Karin, 1995; Crews
et al., 1992; Avruch et al., 1994) (Figure. I). We utilized PD 98059 to determine the
role of these dual specificity (tyr and ser/thr) kinases in the expression of insulin
induced SRE-Luc (Lazar et al., 1995). PD 98059 is a specific inhibitor of MEK that
operates non-competitively with respect to ATP binding ofMEK.
As shown in Figure 8, the 3.0 fold insulin-induced increase in expression of
SRE-Luc was decreased to 1.40 fold upon PD 98059 treatment. These results suggest

that the signal responsible for the insulin-induced expression of SRE-Luc, requires an
activated MEK.
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Effect of Insulin and Inhibitors of the MAPK Cascade on SRE-Luc
Expression. Primary rat hepatocytes in culture were treated with
nothing (control) or insulin (500nM) plus the designated inhibitor of
the MAPK cascade. Values represent the means±S.E. Asterisk (*)
indicates significant stimulation (p<0.05). Double asterisk.(**)
· ,.
indicates significant inhibition. n =4.
Effect of Insulin and Vanadate on JNK Activation

The Jun-N-terminal Kinase (JNK) and ERK.1/2 are two members of the
MAPK family that are implicated in the phosphorylation of ternary complex factors,
such as Elk-1 (Cavigelli et al., 1995; Derijard et al., 1994; Whitmarsh et al., 1995)
(Figure 3). Elk-1 phosphorylation is a necessary step in ternary complex formation
and subsequent activation of SRE-mediated c-fos expression (Cavigelli et al., 1995;
Gille et al., 1992, Gille et al., 1995). Cano et al. have suggested that Elk-1 activation
requires both JNK and ERK MAPK's to elicit a complete nuclear response (Cano et
al., 1995).

Our laboratory. have shown that insulin and vanadate are capable of

activating ERK.1/2 MAPK's in primary rat hepatocytes (data not published). These
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data is in agreement with our data in where inhibition of MEK also causes inhibition
of SRE-Luc expression. Since we have demonstrated that part of the signal used by
insulin in inducing SRE-Luc may require Ras and most likely MEK activation, it
seemed logical to evaluate next the effect of insulin and vanadate on JNK.
In order to determine the effect of insulin and vanadate on the activation of
JNK, JNK assays were carried out as described in Materials and Methods.
Miller et al. reported peak JNK activation 15 min after insulin treatment in Rat
1 fibroblasts overexpressing human insulin receptors (Miller et al., 1996).

We

measured only a small increase of JNK activation 10 min after treatment with insulin.
After 6h of incubation with insulin, a 1.40 fold increase over unstimulated control
was observed (Table 2). This represented a statistically significant activation of JNK
over no addition.

However, · it is unclear if this increase in JNK activation is

significant in the mediation of the insulin-induced SRE-Luc expression.
In order to evaluate the effect of vanadate (500µM) on JNK phosphorylation,
JNK activation was measured after 3h of incubation with the mimetic. As shown in
Table 2, vanadate did not increase JNK activation to any significant extent.
To determine if JNK was possibly involved in mediating the insulin-induced
SRE-Luc, as well as evaluating for cross-talk between the PBK and MAPK cascades,
WT and B581 were tested. As shown in Table 2, both B581 and WT, were effective
inhibitors of JNK activation by insulin. These results suggest that insulin-induced
JNK activity may require activation of Ras and PBK.
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Table 2
Effect of Vanadate, Insulin and Insulin Plus Inhibitors on JNK Activation
in Primary Rat Hepatocytes

Treatment

JN/( Activation llS % of Control

Control

100

V3h

1.28±0.2

16h

1.40±0.08*

I6h+WT

0.82±0.20**

I6h+B

0.83±0.16**

Primary rat hepatocytes in culture received no treatment (control) or were treated with
vanadate (500µM), insulin (I) (500nM), wortmannin (WT) (l00µM), LY 294002
(LY) (50µM), rapamycin (Rap) (l00nM), B581 (50µM) or PD 98059 (PD) (20µM) as
indicated. The control of each experiment was arbitrarily set to 100 and the change
by treatment with vanadate, insulin or inhibitors was expressed compared to the
control value.
Data shown are the means±S.E.
*=significant activation,
**=significant inhibition. p<0.05. Minimum experiment per condition =n=3.

CHAPTER IV
DISCUSSION
The purpose of this study has been to determine the issue of whether or not
vanadate can stimulate the expression of a well-characterized mitogenic gene, c-fos,
using a signal transduction mechanism similar to insulin.
Vanadate has been shown to mimic several of insulin's actions (Posner, et al.,
1994; Goldfine et al., 1995; Tamura et al., 1984). However, the intracellular aspects
of vanadate action has not been clearly established. Therefore, before considering
vanadate as a drug replacement therapeutic agent for diabetes, it is relevant to
establish its effects on proteins associated with the insulin signal transduction
cascades.
To accomplish our goal, we carried out experiments usmg a two-fold
approach. First, transiently transfected primary rat hepatocytes in culture were treated
with insulin and vanadate at various times in order to determine the effect of these
compounds on SRE-mediated gene expression. Second, several inhibitors of the
MAPK and PBK signaling cascades were used in order to determine the possible
signaling pathway(s) used by insulin and vanadate.
The SRE-Luc plasmid obtained from Dr. Jeffrey Pessin's Laboratory is an
effective reporter of some of insulin's action in the cell (Yamauchi et al., 1993). The
5500bp-long construct contained a dyad (44bp) of symmetric SRE cis-elements that
mediate the expression of the construct upon serum and insulin presence (Treisman,
1986; O'Brien et al., 1996). This dyad is surrounded by 59bps on each side, which
are necessary for the full transcriptional response (Yamauchi et al., 1993). The SRE31
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Luc dyad is linked to a thymidine kinase (tk) promoter (270bp) (Chen et al., 1987)
and a luciferase gene (181 l bp), as described by de Wet et al. (de Wet et al., 1987).
The SRE-Luc construct had been previously tested with regard to insulin
induction in Chinese hamster ovary cells expressing high levels of the insulin receptor
(CHO-IR) (Yamauchi et. al, 1993). Yamauchi et al. reported a maximum increase of
14-fold of SRE-Luc observed between 4h to 6h of insulin treatment (Yamauchi et. al,
1993). In our model, primary rat hepatocytes, SRE-Luc showed a 3-fold maximum
increase between 3h and 6h of insulin treatment.
The higher plasmid expression levels observed m CHO-IR upon insulin
induction represents amplified signals of multiple individual insulin receptor
molecules enhancing the activation of the signal cascade proteins. These multiple
insulin receptors are not present in the plasma membranes of the primary rat
hepatocytes. Since primary rat hepatocytes closely resemble the liver and its actions
as a primary target organ of insulin induction, the insulin-induced SRE-Luc
expression levels observed in the hepatocytes better resemble the levels observed in
vivo. Consequently, it was expected that the plasmid expression levels in CHO-IR
and primary hepatocytes would differ. However, it was interesting to note that in
both models, the incubation time for maximum SRE-Luc expression caused by
insulin was very similar. In both, hepatocytes and CHO-IR, the maximum insulin
induced plasmid expression was observed between 4h and 6h. Therefore, in both
models, insulin activates mechanisms of protein phosphorylation and gene expression
within a similar time frame.
Since vanadate has been shown to activate the insulin signal cascades in
response to metabolic effects, such as glucose transport and protein synthesis (Osamu
et al., 1990; Balon et al., 1995; Goldfine et al., 1995; Yale et al., 1995), we decided
instead to test the ability of vanadate to induce, in a fashion similar to insulin, the
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expression of the SRE-driven reporter plasmid. Our results show that, even though,
insulin (500nM) induced SRE-Luc expression, vanadate (500µM) did not induce
expression of the plasmid to any significant extent. These results suggest that if
vanadate induces the activation of the c-fos gene in vivo, it operates through a
different mechanism than insulin. This has also been proposed by Chen and Chan
who reported that vanadate and insulin induced c-fos expression in 3T3-Ll cells by
stimulation of different cis-elements (Chen and Chan, 1993). Still others (Wang et
al., 1994) suggest that differences in insulin and vanadate actions are due to
differences in phosphorylation of signal molecules. However, irrespective of the
possible mechanisms of action of insulin and vanadate, our results indicate that, in
primary rat hepatocytes, vanadate does not induce gene expression through an SRE as
insulin does. These results imply that vanadate does not trigger the same events as
insulin.
Once we had determined that insulin induced the expression of the reporter
plasmid through SRE, we were interested in determining the signals behind this
activation.
In order to determine which proteins were activated by insulin-induced
expression of SRE-Luc in our model, and consequently, the possible pathway(s) used
in this process, we used several known inhibitors of the MAPK and PI3K signal
cascade proteins. The level of SRE-Luc expression measured after treatment with
insulin and the inhibitors helped characterize the role of the proteins in the signaling
mechanism of insulin.
We found that two mechanistically different inhibitors of PI3K, WT and LY
294002, completely blocked the insulin-induced SRE-Luc expression in primary rat
hepatocytes. Both of these inhibitors, in the presence of insulin, returned SRE-Luc
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expression to no addition levels; which suggests that activation of PBK is a necessary
step in the expression of this plasmid by insulin in primary rat hepatocytes.
Similarly, treatment with the MEK inhibitor PD 98059, resulted m a
significant inhibition of insulin-induced SRE-Luc expression,.which suggests that the
insulin-induced SRE-Luc expression in rat hepatocytes may require not only PBK but
also the activation of the MAPK pathway. Interestingly, we also found that inhibition
of Ras activation by B581 resulted in inhibition of the insulin-induced plasmid
expression. This suggests an interaction between the Ras/MAPK and PBK signaling
pathways. The involvement of phosphatidylinositol 3-kinase in the activation of Ras
and similar proteins of the MAPK signaling cascade has been examined by several
studies with results similar to ours (Hawes et al., 1996; Hu et al., 1995; Cross et al.,
1994). For example, Hawes et al. established that wortmannin and LY 294002,
inhibitors of PI3K, completely blocked MAPK activity (Hawes et al., 1996). These
studies, however, differ with regard to the exact site of action of PBK in the MAPK
cascade. There are several possibilities which have been considered, however, these
differences seem to be also related to cell specificity.
The data we collected suggests that PBK is necessary for the insulin-induced
expression of SRE-Luc. However, since the expression of SRE-Luc is only slightly
reduced by inhibition of Ras and almost completely blocked by inhibition of MEK, it
could be suggested that PBK is located somewhere between Ras and MEK. This
relationship has been considered previously by Suga et al., who has recently reported
that insulin-activated PI3K is involved in the interaction between Ras and Raf-1 in
3T3-Ll cells (Suga et al., 1997). Some studies have also reported that in muscle
cells, insulin and IGF-1 induced gene expression by activating proteins involved in
the PBK and MAPK cascades. Gene expression, in muscle cells, required PBK
activation which in turn, activated both the MAPK and PBK pathways (Tansey et al.
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1996, Cross et al., 1994). This relationship has been reported by several other studies
that increasingly suggest crosstalk between the MAPK and PBK cascades (Tansey et
al., 1996; Band and Posner, 1997).
Even though, several studies have suggested interaction between PBK and
Ras/MAPK (Jhun et al. 1994a, Suga et al. 1997; Yamauchi et al. 1993; Cross et al.,
1994; Welsh et al., 1994; Hu et al., 1995; Hawes et al, 1996; Standaert et al., 1995),
several other studies have suggested that PBK and Ras/MAPK pathways do not
interact with each other.

This difference in observations can be reconciled by

considering that several of the studies that show no interaction between PBK and
Ras, have used different hormones which act on different target organs with different
specificity (Harada et al., 1995; Yamamoto-Honda et al., 1995; Gabbay et al., 1996).
FRAP, a downstream effector of PBK has been reported to participate in the
activation of p70S6Kinase (Choi et al., 1996; Shepherd et al., 1995; Brown et al.,
1995; Monfar et al., 1995). Addition of rapamycin, a FRAP inhibitor, partially
blocked the insulin-induced expression of SRE-Luc.

Since FRAP binding to

p70S6Kinase is a required step for p70S6Kinase activation, these results suggest the
involvement of FRAP, p70S6Kinase or both in the expression of SRE-Luc by insulin
(Brown et al., 1995).
The proteins that participate in the activation of p70S6Kinase are not well
characterized. However, Monfar et al. determined that at least, two possible unrelated
pathways could be responsible for the activation of p70S6Kinase. One of them is
rapamycin-sensitive and the other is wortmannin-sensitive (Monfar et al., 1995). The
two pathways act independently for the activation of p70S6Kinase. These results and
others from similar studies could be used to explain the significant, but partial
decrease in insulin-induced SRE-Luc expression observed in our model upon

36
treatment with rapamycin (Banerjee et al., 1990; Shepherd et al., 1995; Monfar et al.,
1995).
Since our laboratory previously showed that insulin and vanadate were
capable of activating ERK.1/2 MAPK's in primary rat hepatocytes (data not
published), we decided it was important to assess their effect on JNK.
JNK, a member of the MAPK family has been implicated m the
phosphorylation of c-Jun, which is a necessary step in AP-1 post-transcriptional
modification. JNK as well as ERK.1/2 have been implicated in the phosphorylation of
the ternary complex factor Elk-1 (Cavigelli et al., 1995; Derijard et al., 1994;
Whitmarsh et al., 1995), which is required for ternary complex formation and
activation of SRE-mediated c-fos expression (Cavigelli et al., 1995; Gille et al., 1992,
Gille et al., 1995). Cano et al. have determined that in some cell models Elk-1
activation requires both JNK and ERK MAPK's to elicit a complete nuclear response
(Cano et al., 1995). These observations determined the second aspect of our study:
assessment of JNK activation by insulin and vanadate in primary rat hepatocytes.
Miller et al. reported peak JNK activation (2.5 fold increase over unstimulated
controls) 15 min after insulin treatment in Rat 1 fibroblasts overexpressing human
insulin receptors (Miller et al., 1996). These activation levels, however, were not
compatible with the activation levels we observed by insulin treatment in primary rat
hepatocytes. In the hepatocytes, we measured only a small increase of JNK activation
10 min after treatment with insulin. The maximum activation of 1.40 fold was
observed after 6h.
Some observations by Lopez-Ilasaca et al., suggested that activation of PI3K
is a requirement for the activation of JNK by some growth hormones such as insulin
(Lopez-Ilasaca et al., 1997). We decided to determine the relationship between PI3K,
Ras and JNK, by using the inhibitors B581 and WT. We found that the use of Ras
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and PBK inhibitors decreased the activation ofJNK by insulin. These findings are in
agreement with the observations ofLopez-Ilasaca et al., and complement our previous
results that suggested that activation of both PBK and Ras were involved in insulin
induction ofthis plasmid expression.
Unlike insulin, vanadate did not increase JNK activation to any significant
extent. Since in our laboratory, vanadate has shown activation of ERKl/2 MAPK's
(data not published), it can be suggested that, in mediating its insulin-like effects, this
element activates ERKl/2 and not JNK. It may also be suggested, since insulin
induced JNK activity and not vanadate, that JNK is required for the induction of SRE
Luc.
The results obtained by determining the insulin and vanadate activation of
JNK in primary rat hepatocytes suggested, once again, that vanadate and insulin did
not operate in a similar manner with regard to the insulin signal proteins that they
activate.
This study showed that insulin increased expression of SRE-Luc in a time
dependent fashion while vanadate did not. Use of inhibitors of the PBK and MAPK
pathways suggested that PBK is necessary and the protein maybe located somewhere
between Ras and MEK for the insulin-induced expression ofthis plasmid. The use of
inhibitors also helped determine that MAPK pathway proteins maybe involved in the
insulin-induced expression ofthe plasmid.
Additionally, since only insulin treatment resulted in JNK activation our
results show yet another way that insulin and vanadate do not similarly act.
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Abbreviations

38

39
Abbreviations: AP-1, activator protein-I; ATF2, activating transcription factor 2;
BSA, bovine serum albumin; CHO, Chinese hamster ovary cells; CHO-IR, CHO
overexpressing human insulin receptor; CRE, cAMP-response element; EGF,
epidermal growth factor; ERK, extracellular signal regulated kinase; FRK, fos
regulating kinase; Grb2, growth factor receptor bound protein 2; IGF-1, insulin-like
growth factor 1; IL, interleukin; IR, insulin receptor; IRS-1, insulin receptor substrate
1; JNK, Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MAPKAP
K, mitogen-activated protein kinase-activated protein kinase; MAPKKK, mitogen
activated protein kinase kinase kinase; MEK, MAP kinase/ERK-activating kinases
PDGF, platelet-derived growth factor; PI3K, phosphatidylinositol 3-kinase; rsk,
90KDa ribosomal S6 Kinase; SAPK, stress-activated protein kinase; SH2 and SH3, src
homology domains; SIE, sis-inducible enhancer; S6 K, 70KDa ribosomal S6 kinase;
SOS, son of sevenless; SRE, serum response element; SRF, serum response factor;
TCF, ternary complex factor; tk, thymidine kinase; TPA, 12-tetradecanoyl-phorbol13-acetate; TRE, TPA response element; UV, ultraviolet light; WT, wortmannin
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